Course and clinical severity of the SARS-CoV-2 Omicron variant infection in Tianjin, China

被引:2
作者
Ren, Yi [1 ,2 ]
Shi, Lixia [1 ,2 ]
Xie, Yi [1 ,2 ]
Wang, Chao [1 ,2 ]
Zhang, Wenxin [1 ,2 ]
Wang, Feifei [1 ,2 ]
Sun, Haibai [1 ,2 ]
Huang, Lijun [1 ,2 ]
Wu, Yuanrong [1 ,2 ]
Xing, Zhiheng [1 ,2 ]
Ren, Wenjuan [1 ,2 ]
Heinrich, Joachim [3 ,4 ]
Wu, Qi [2 ,5 ]
Pei, Zhengcun [5 ]
机构
[1] Tianjin Univ, Haihe Hosp, Tianjin, Peoples R China
[2] Tianjin Inst Resp Dis, Tianjin, Peoples R China
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst & Clin Occupat Social & Environm Med, Munich, Germany
[4] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Melbourne, Australia
[5] Tianjin Univ, Med Coll, Tianjin, Peoples R China
关键词
children; course; illness severity; Omicron; SARS-Cov-2;
D O I
10.1097/MD.0000000000034669
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is limited information describing the course and severity of illness in subjects infected by the severe acute respiratory syndrome coronavirus 2 Omicron variant, especially in children. In this population-based cohort study, subjects with Omicron variant infection during the outbreak between January 8 and February 12, 2022 in Tianjin, China were included (n = 429). The main outcomes were the distribution of asymptomatic, mild, moderate, and severe patients, and clinical courses including the interval from positive polymerase chain reaction (PCR) test to the onset, aggravation or relief of symptoms, and the interval of reversing positive PCR-test into negative, and length of hospital stay. Of the 429 subjects (113 [26.3%] children; 239 [55.7%] female; median age, 36 years [interquartile range 15.0 to 55.0 years]), the proportion (95% CI) of symptomatic subjects on admission was 95.6% (93.2%, 97.2%), including 60.4% (55.7%, 64.9%) mild, 35.0% (30.6%, 39.6%) moderate, and 0.2% (0.0%, 1.3%) severe. Compared with adults, children had lower proportion of moderate Covid-19 (8.8% vs 44.3%). On discharge, 45.9% (41.3%, 50.7%) and 42.2% (37.6%, 46.9%) of the subjects were diagnosed as having experienced mild and moderate Covid-19. The median (interquartile range) length of hospital stay was 14.0 (12.0, 15.0) days. The median interval of reversing positive PCR-test into negative was 12.0 (10.0, 13.0) days. Symptomatic and moderate Covid-19 in Omicron infections was common in adults and children, recovery from Omicron infections took around 2 weeks of time. The severe acute respiratory syndrome coronavirus 2 Omicron infection in this study was not as mild as previously suggested.
引用
收藏
页数:8
相关论文
共 23 条
  • [1] Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
    Accorsi, Emma K.
    Britton, Amadea
    Fleming-Dutra, Katherine E.
    Smith, Zachary R.
    Shang, Nong
    Derado, Gordana
    Miller, Joseph
    Schrag, Stephanie J.
    Verani, Jennifer R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (07): : 639 - 651
  • [2] Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
    Altarawneh, Heba N.
    Chemaitelly, Hiam
    Hasan, Mohammad R.
    Ayoub, Houssein H.
    Qassim, Suelen
    AlMukdad, Sawsan
    Coyle, Peter
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Benslimane, Fatiha M.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar H.
    Latif, Ali N.
    Shaik, Riyazuddin M.
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed G.
    Butt, Adeel A.
    Al-Romaihi, Hamad E.
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Tang, Patrick
    Abu-Raddad, Laith J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13) : 1288 - 1290
  • [3] Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant
    Bhattacharyya, Roby P.
    Hanage, William P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (07)
  • [4] China National Health Commission, 2021, Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 8)
  • [5] Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
    Hall, Victoria
    Foulkes, Sarah
    Insalata, Ferdinando
    Kirwan, Peter
    Saei, Ayoub
    Atti, Ana
    Wellington, Edgar
    Khawam, Jameel
    Munro, Katie
    Cole, Michelle
    Tranquillini, Caio
    Taylor-Kerr, Andrew
    Hettiarachchi, Nipunadi
    Calbraith, Davina
    Sajedi, Noshin
    Milligan, Iain
    Themistocleous, Yrene
    Corrigan, Diane
    Cromey, Lisa
    Price, Lesley
    Stewart, Sally
    de Lacy, Elen
    Norman, Chris
    Linley, Ezra
    Otter, Ashley D.
    Semper, Amanda
    Hewson, Jacqueline
    D'Arcangelo, Silvia
    Chand, Meera
    Brown, Colin S.
    Brooks, Tim
    Islam, Jasmin
    Charlett, Andre
    Hopkins, Susan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13) : 1207 - 1220
  • [6] Kozlov Max, 2022, Nature, DOI 10.1038/d41586-022-00309-x
  • [7] Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose
    Kuhlmann, Constanze
    Mayer, Carla Konstanze
    Claassen, Mathilda
    Maponga, Tongai
    Burgers, Wendy A.
    Keeton, Roanne
    Riou, Catherine
    Sutherland, Andrew D.
    Suliman, Tasnim
    Shaw, Megan L.
    Preiser, Wolfgang
    [J]. LANCET, 2022, 399 (10325) : 625 - 626
  • [8] Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves
    Maslo, Caroline
    Friedland, Richard
    Toubkin, Mande
    Laubscher, Anchen
    Akaloo, Teshlin
    Kama, Boniswa
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (06): : 583 - 584
  • [9] Modes Matthew E, 2022, MMWR Morb Mortal Wkly Rep, V71, P217, DOI 10.15585/mmwr.mm7106e2
  • [10] Omicron severity: milder but not mild Comment
    Nealon, Joshua
    Cowling, Benjamin J.
    [J]. LANCET, 2022, 399 (10323) : 412 - 413